|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,419.00 JPY | +1.62% |
|
+1.47% | +11.35% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,137B 7.15B 6.19B 5.79B 5.29B 9.97B 682B 10.12B 67.87B 26.63B 341B 26.86B 26.27B | P/E 2027 * |
15.9x | P/E 2028 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 936B 5.89B 5.1B 4.77B 4.36B 8.21B 562B 8.34B 55.91B 21.94B 281B 22.12B 21.64B | EV / Sales 2027 * |
2.06x | EV / Sales 2028 * | 2x |
| Free-Float |
80.98% | Yield 2027 * |
3.24% | Yield 2028 * | 3.21% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.62% | ||
| 1 week | +1.47% | ||
| Current month | +1.47% | ||
| 1 month | -1.22% | ||
| 3 months | -2.48% | ||
| 6 months | -5.06% | ||
| Current year | +11.35% |
| 1 week | 2,264.5 |  | 2,423 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.62% | +1.47% | +41.67% | -12.77% | 7.09B | |
| -0.03% | -2.32% | +22.53% | +68.67% | 49.03B | |
| -1.14% | +13.15% | +60.80% | +127.29% | 42.33B | |
| +0.27% | -0.37% | -1.22% | +15.93% | 12.43B | |
| +0.43% | -0.69% | +19.53% | +69.15% | 11.68B | |
| +3.84% | +0.19% | +30.98% | +140.74% | 9.12B | |
| +3.81% | +8.39% | +22.04% | +39.32% | 7.15B | |
| -1.22% | +0.78% | +11.47% | +171.70% | 6.76B | |
| +0.03% | +8.29% | -24.59% | +28.71% | 5.95B | |
| +0.49% | +1.18% | +34.57% | +100.44% | 4.58B | |
| Average | +0.41% | +2.10% | +21.78% | +74.92% | 15.61B | |
| Weighted average by Cap. | -0.07% | +1.66% | +30.21% | +83.43% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.86B 2.48B 2.32B 2.12B 3.99B 273B 4.05B 27.15B 10.65B 137B 10.74B 10.51B | 445B 2.8B 2.42B 2.26B 2.07B 3.9B 267B 3.96B 26.55B 10.42B 133B 10.51B 10.28B |
| Net income | 71.42B 449M 389M 364M 332M 626M 42.86B 636M 4.26B 1.67B 21.44B 1.69B 1.65B | 62.78B 395M 342M 320M 292M 551M 37.68B 559M 3.75B 1.47B 18.85B 1.48B 1.45B |
| Net Debt | -200B -1.26B -1.09B -1.02B -933M -1.76B -120B -1.79B -11.97B -4.7B -60.17B -4.74B -4.63B | -248B -1.56B -1.35B -1.26B -1.16B -2.18B -149B -2.21B -14.82B -5.82B -74.52B -5.86B -5.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | JP¥2,419.00 | +1.62% | 1,335,600 |
| 26-08-07 | JP¥2,380.50 | +1.82% | 1,307,700 |
| 26-08-06 | JP¥2,338.00 | +1.61% | 1,513,200 |
| 26-08-05 | JP¥2,301.00 | -0.26% | 1,636,100 |
| 26-08-04 | JP¥2,307.00 | -1.30% | 2,047,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
